Vericel Corporation (VCEL)

44,71 -0,01 (-0,02%) Ab 12:15PM EDT. Markt geöffnet.

Vericel Corporation

64 Sidney Street
Cambridge, MA 02139
United States
617 588 5555
https://vcel.com

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 314

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Dominick C. Colangelo Esq.	CEO, President & Director	1,54M	1,51M	1964
Mr. Joseph Anthony Mara Jr.	CFO & Treasurer	750,61k	N/A	1976
Mr. Michael Halpin	Chief Operating Officer	796,91k	492,26k	1962
Mr. Sean C. Flynn	Chief Legal Officer	657,01k	N/A	1974
Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B.	Chief Medical Officer	672,16k	127,25k	1962
Mr. Jonathan D. Siegal	Principal Accounting Officer, VP & Corporate Controller	N/A	N/A	N/A
Mr. Eric Burns	Vice President of Finance & Investor Relations	N/A	N/A	N/A
Mr. Patrick J. Fowler	Senior Vice President of Corporate Development & Strategy	N/A	N/A	N/A
Mr. Patrick Helfrich	Vice President of Marketing & Commercial Strategy	N/A	N/A	N/A
Mr. Mike Gilligan	Senior Vice President of Sales	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

Corporate Governance

Vericel Corporations ISS Governance QualityScore, Stand 1. September 2024, lautet 4. Die grundlegenden Scores sind Audit: 7, Vorstand: 3, Shareholderrechte: 4, Kompensation: 6.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.